Feed Preview

Fast Growing

ApoE Phenotypes

ApoE Phenotypes diagram by undefined

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Top 20 most recent papers
PLoS Medicine

Variation in blood pressure and long-term risk of dementia: A population-based cohort study

PLoS MedicineNovember 1, 2019
Yuan MaMohammad Kamran Ikram
15
5
Neurology

APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort

NeurologyNovember 8, 2019
Sandra WeintraubM-Marsel Mesulam
1
1
International Journal of Geriatric Psychiatry

Long-term dementia risk prediction by the LIBRA score: a 30-year follow-up of the CAIDE study

International Journal of Geriatric PsychiatryNovember 17, 2019
Kay DeckersAlina Solomon
Clinical Journal of the American Society of Nephrology : CJASN

APOL1 Nephropathy Risk Alleles and Risk of Sepsis in Blacks

Clinical Journal of the American Society of Nephrology : CJASNNovember 8, 2019
Ninad S ChaudharyOrlando M Gutiérrez
5
PloS One

Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses' Health Study

PloS OneNovember 7, 2019
Iris Y KimDavid James Hunter
1
Proceedings of the National Academy of Sciences of the United States of America

Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina

Proceedings of the National Academy of Sciences of the United States of AmericaNovember 7, 2019
Shoji NotomiDemetrios G. Vavvas
International Heart Journal

Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice

International Heart JournalNovember 15, 2019
Kunduziayi AiniMasataka Sata
Atherosclerosis

Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice

AtherosclerosisNovember 2, 2019
Pathricia Veronica TilstamHeidi Noels
Journal of Cardiovascular Pharmacology and Therapeutics

Intermedin1-53 Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum Stress

Journal of Cardiovascular Pharmacology and TherapeuticsNovember 7, 2019
Jin-Ling RenYong-Fen Qi
Translational Vision Science & Technology

Selective Retina Therapy Reduces Bruch's Membrane Thickness and Retinal Pigment Epithelium Pathology in Age-Related Macular Degeneration Mouse Models

Translational Vision Science & TechnologyNovember 1, 2019
Jan TodeJohann B Roider
Translational Psychiatry

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals

Translational PsychiatryNovember 7, 2019
Sung Yeon Sarah HanSabine Bahn
Environmental Health Perspectives

Screening of House Dust from Chinese Homes for Chemicals with Liver X Receptors Binding Activities and Characterization of Atherosclerotic Activity Using an in Vitro Macrophage Cell Line and ApoE - / - Mice

Environmental Health PerspectivesNovember 1, 2019
Wenxin HuJian-Ying Hu
1
Journal of Agricultural and Food Chemistry

Fish oil is more potent than flaxseed oil in modulating gut microbiota and reducing trimethylamine-N-oxide (TMAO)-exacerbated atherogenesis

Journal of Agricultural and Food ChemistryNovember 18, 2019
Zouyan HeZhen-Yu Chen
Annals of Clinical and Translational Neurology

Study partner-reported decline identifies cognitive decline and dementia risk

Annals of Clinical and Translational NeurologyNovember 13, 2019
Rachel L NoshenyAlzheimer’s Disease Neuroimaging Initiative investigators
1
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Practical algorithms for amyloid β probability in subjective or mild cognitive impairment

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringNovember 9, 2019
Nancy Nairi MaserejianFeng Gao
3
1
Organic & Biomolecular Chemistry

Theoretical insights into the E1cB/E2 mechanistic dichotomy of elimination reactions

Organic & Biomolecular ChemistryNovember 11, 2019
Daniela E OrtegaRicardo A. Matute
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE-/- Mice

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryNovember 15, 2019
Lili GuShuhua Tan
1
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences

Varying Effects of APOE Alleles on Extreme Longevity in European Ethnicities

The Journals of Gerontology. Series A, Biological Sciences and Medical SciencesNovember 13, 2019
Anastasia Gurinovichpaola sebastiani
Bone

High LDL levels lessen bone destruction during antigen-induced arthritis by inhibiting osteoclast formation and function

BoneNovember 9, 2019
Giuliana AsconePeter L E M van Lent
Neurobiology of Aging

What are the threats to successful brain and cognitive aging?

Neurobiology of AgingNovember 1, 2019
Michela GallagherPeter R Rapp

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2019 Meta ULC. All rights reserved
/feed-previews/apoe-phenotypes/5f08b7b2-e8f9-419f-ac8f-e19485a1800c